H2-receptors predominantly mediate pial arteriolar dilatation in re sponse to histamine, but the reaction of pial veins to histamine has not been clearly identified. In anesthetized cats, we examined responses of pial veins and arterioles to perivascular microapplication of histamine and specific his tamine HI and H2 receptor agonists. Arterioles were very sensitive to the
H2-receptor agonist impromidine, with significant dilatation (+ 16%) occurring at concentrations as low as 10-10 M. Arteriolar responses to HI receptor stimu lation by 2,2-pyridylethylamine were small, even at high concentrations. The order of potency and maximum dilatations found for the receptor agonists were: H2 (43%) > histamine (28%) > HI (17%). By contrast, pial veins did not respond to histamine or the receptor agonists. The results indicate that pial venomotor activity to histamine is negligible, and suggest a sparse distribution of histamine receptors on the outer surfaces of pial veins. Key Words: HI and H2 receptors-Cat brain-2,2-Pyridylethylamine-Impromidine Vascular distribution of histamine receptors.
The Monro-Kellie doctrine, which evolved from theoretical considerations and post-mortem exami nations, proposed that alterations in brain volume were unlikely to occur because the flow of cerebral blood was passive in a rigid compartment (Monro, 1783; Kellie, 1824) . This concept implied that brain capacitance vessels have no capability of influenc ing the cerebral blood volume, a consideration that, even today, remains largely untested.
In peripheral organs, venous mechanisms are better understood. It is clear that veins in many of the vascular beds examined are responsive to sev eral neurohumoral stimuli (Donegan, 1921; Folkow and Neil, 1971; Shepherd and Vanhoutte, 1975; Ab-boud et ai., 1976) . Although histamine is richly lo cated in stores near and within brain blood vessels (EI-Ackad and Brody, 1974; Edvinsson et ai., 1977; Schwartz et ai., 1980) , its influence on the cerebral venous circulation has not been elucidated.
We examined responses of pial veins to perivas cular injection of histamine and its receptor agonists. Histamine is one of the most vasoactive of biogenic amines (Beaven, 1976; Rossi, 1979; Brody, 1980) . It has been demonstrated previously to have receptors in cerebral arteries (Edvinsson and Owman, 1975) and evokes strong dilatations of pial arterioles in situ (Wahl and Kuschinsky, 1979a) .
With these experiments, we extended the obser vations of Wahl and Kuschinsky (I979a) by study ing pial arteriolar responses to perivascular appli cation of specific histamine HI and H2 receptor agonists. Marked differences in the potencies of these receptor stimulants for producing arteriolar dilatation were found. We further considered the possibility that histamine receptor agonists may have potent effects on cerebral veins.
METHODS
Thirty-two cats of both sexes, weighing 2-5 kg, were used. Anesthesia was induced by intravenous injection of Saffan® (alphaxone, 6. 75 mg kg-l and alphadolone acetate, 2. 25 mg kg-I ; Glaxovet, Greenford, England). Catheters were inserted into a femoral vein and artery. The trachea was intubated, and the cats were mechanically ventilated with air and oxygen to maintain arterial POt greater than 100 mm Hg, and arterial Peot between 30 and 35 mm Hg. Anesthesia was maintained by intravenous in jection of a-chloralose in doses of 50 mg kg-I , given as needed during the study. End-tidal CO2, arterial blood pressure, and body temperature were measured continuously, and samples of arterial blood were taken frequently for blood gas and pH analysis. When required, gallamine triethiodide (10 mg kg-l h-l, i. v. ) was used for paralysis of skeletal muscles.
The head of the cat was positioned in a stereotaxic frame, and a longitudinal incision was made along the scalp. Skin, fasciae, and muscle were cleared from the bone and retracted with liga tures onto a metal ring so that the skin formed a deep pool over the skull. A dental drill, cooled with saline, was used to cut a hole (2 x 1 cm) in the parietal calvarium. The exposed dura and skull surface were then bathed in heated mineral oil (liq uid paraffin), which was circulated continuously over the surgical field at a depth of 15 mm. A therm istor positioned near the craniotomy permitted constant monitoring of the bath temperature, which was maintained at 37 -38°C. The dural membrane was cut and retracted to expose the cortex (ectosyl vian and suprasylvian gyri) and pial vessels.
The field was brightly illuminated and was ex amined through a stereomicroscope at x 40 or x 70 magnification. Vessel images were passed through a television camera mounted on the microscope and were displayed on a monitor in the laboratory. The diameter of a given vessel was determined by an image-splitting technique (Baez, 1966) using a de vice connected to the microscope and television camera. Filaments of known diameter were used to calibrate the system before each study.
This technique for studies of pial vessel responses J Cereh Blood Flow Metahol, Vol. I, No. 2, 1981 to perivascular injection of vasoactive substances has been applied before by Wahl and associates Kuschinsky, 1977, 1979a,b; Kuschin sky et aI. , 1972 Kuschin sky et aI. , , 1979 , Harper and MacKenzie (1977) , and McCulloch and Edvinsson (1980) . We randomly selected several pial arterioles and veins at the beginning of each experiment. At normal arterial pressure (between 90 and 120 mm Hg), the resting diameters of vessels in these experiments were between 36 and 281 p,m. Several concentrations of histamine agents were injected to determine the concentration-response relationships in both arterioles and veins; there was no order of the concentrations used for a particular drug in any one experiment.
Solutions were made fresh the day of each ex periment. Mock cerebrospinal fluid (CSF) was used as the solvent for the test substances. Composition of the mock CSF (in mM) was: NaCI, 144; Kf, 3; Ca 2 +, 5; HCO:l-, 12. pH was adjusted to 7.18, a value similar to that found in subarachnoid fluid during normal conditions (Kuschinsky and Wahl, 1979; Wahl and Kuschinsky, 1979b) . At these HCO:l-and H+ concentrations, there is no pial arte rial response to perivascular administration of the CSF (Kuschinsky et aI. , 1972;  see Results below). The drugs used in these experiments were his tamine dihydrochloride (Sigma); 2,2-pyridylethyl amine (Smith Kline & French), which is an H I re ceptor agonist (Durant et aI. , 1975) ; and impromidine (Smith Kline & French), an agonist at H2 receptors (Durant et aI. , 1978) . Glass pipettes with tip di ameters of 8-10 p,m were filled with the agents and mounted on a micromanipulator. The pipette tip was positioned through the arachnoid membrane, and about 3 p,l of fluid was injected into the space surrounding the blood vessel. Resulting changes in vascular diameter were measured repeatedly for several minutes until the vessel began to return to its control diameter. The observed changes in vas cular caliber were expressed as a percentage change from the pre-injection, control diameter of the vessel.
To test statistically for changes in vascular re sponse from the control state, results were evalu ated by analysis of variance and the Scheffe multi ple comparison test (Winer, 1971) . A minimum level of significance was accepted at p < 0.05.
RESULTS

Arterioles
Perivascular injection of mock CSF had no sig nificant effect on arteriolar diameter (percentage change from control = -2 ± 2%, n = 82 vessels in 30 cats).
Responses to histamine were established over a range of four doses from 10-10 to 10-4 M in vessels having control diameters from 38 to 212 /-Lm. Small dilatations resulted at doses of 10-10 and 10-8 M, but responses were greater at 10-6 and 10-4 M (Fig. 1) . The maximum response demonstrated with his tamine occurred at 10-4 M (28% increase in vessel diameter from control).
The HI receptor agonist, pyridylethylamine, was studied at five concentrations between 10-7 and 10-3 M in vessels with sizes between 36 and 274 /-Lm. This drug produced only weak dilatatory responses at all doses examined, and in all sizes of vessels. The threshold for dilatation with pyridylethylamine was 10-6 M (10% increase in caliber), and the maximum response occurred at 10-4 M (17%) (Fig. l) .
Six concentrations of the Hz receptor agonist im promidine were studied in vessels 36-259 /-Lm in control diameter. This drug produced significant dilatations of arterioles at concentrations as low as 10-10 M (16% increase in vessel caliber). The maximum dilatation produced by impromidine oc curred at 10-6 M (43% increase in vessel caliber) ( Fig. 1) .
Because impromidine proved to be an active and potent drug at pial arterioles, a further analysis was undertaken to evaluate the possible relationship of vessel size to magnitude of response. At the con centrations producing the largest increases in vessel caliber (10-7-10-4 M, n = 31 vessels), there was no significant relationship between initial vessel size and the magnitude of response to impromidine. However, when vessel responses were partitioned between the lowest size limit «80 /-Lm) and the highest (> 155 /-Lm), there was a tendency for differ ence with regard to size and response. Small vessels tended to be more responsive: they had an increase in caliber of 45 ± 4%, whereas large vessels had an increase of 35 ± 4% (n = 9 each).
Veins
Veins did not respond significantly to perivascu lar injection of mock CSF (+4 ± 2%, n = 15 vessels in 6 cats; p > 0. 05).
For each of the histamine agents, venous re sponses were examined at two concentrations. For histamine itself, there was no significant effect on venous caliber at either of the concentrations studied (range of initial diameters, 69-281 /-Lm). At 10-6 and 10-4 M, vein responses to perivascular in jection were 2 and 4%, respectively (p > 0. 05 with respect to pre injection control caliber of the vessel) ( Fig. 2) .
For the HI receptor agonist pyridylethylamine, which was studied at concentrations of 10-5 and 10-3 M (vessel calibers 55-266 /-Lm), responses were 1 and 5%, respectively (p > 0. 05) (Fig. 2) .
Similarly, impromidine, the H2 receptor agonist, did not produce significant changes in venous caliber in vessels 69-281 /-Lm in initial diameter. Responses to 10-8 and 10-6 M were 0 and 5%, re spectively (p > 0. 05) (Fig. 2) . 
RESPONSES OF PIAL
DISCUSSION
These studies demonstrate that stimulation of histamine receptors with specific H I and Hz recep tor agonists produces dilatation of pial arterioles. The magnitude of arteriolar dilatation was related to the type of receptor stimulated; Hz receptors were more potent than HI receptors. In pial veins, there was no significant response of the vessels to con centrations of histamine receptor agonists that pro duced clear effects in arterioles. The discussion will focus on factors that could account for these discrepancies between the arteriolar and venous segments of the pial circulation.
Responses of Arterioles
The results demonstrate that histamine, and each of the histamine receptor agonists, produces dilata tion of pial arterioles when the drug is given by perivascular microinjection. Histamine produced increases in arteriolar caliber up to + 28% at a con centration of 10-4 M; this result confirms previous findings in another laboratory (Wahl and Kus chinsky, 1979a) .
The new information in this study was the evi dence for histamine HI receptors being located on the outside of brain arterioles. Moreover, an order of potency for dilatation could be established for the stimulants of histamine receptors: Hz > histamine > H I (Fig. 1) .
Because histamine HI receptors have been previ ously identified in brain tissue preparations (Schwartz, 1979) , it is not surprising that H I recep-J Cereb Blood Flow Metabol. Vol. I. No. 2. 1981 tors are located in pial arterioles. Both HI and Hz receptors have been functionally identified in most preparations for studying cardiovascular responses to histamine (Owen, 1977) . Wahl and Kuschinsky (1979a) found that histaminergic dilatation of brain arterioles was mediated almost entirely by Hz re ceptors, a conclusion made on the basis of studies with histamine receptor blocking agents. In the present experiments, specific receptor agonists were used. These agents disclosed the presence of both H I and Hz receptors.
The smaller response of pial arterioles to H I re ceptor stimulation may be related to the density of this type of receptor on the outside of the vessel wall. It is possible that H2 receptors are more densely populated, and HI receptors more sparsely populated, along the outer layers of smooth muscle in brain arterioles. Brody and colleagues have suggested that this may be the pattern of histamine receptor distribution in skeletal muscle and cutane ous vessels Galeno et aI., 1979; Brody, 1980) . The Hz receptor agonist impromidine was found to produce larger dilatations from perivascular ap plication than histamine itself. Three possible ex planations for this result are: (1) Impromidine has high and specific affinity for H2 receptors (Durant et aI., 1978) and is more potent than histamine for stimulating Hz receptors in the cardiovascular sys tem (Owen et aI., 1979) .
(2) Because of its chemical structure, histamine may preferentially bind to H I receptors (Durant et aI., 1975; Brody, 1980) ; if H I receptors have low potency for producing pial ar teriolar responses, and are more sparsely distrib uted along the outer surfaces of pial arterioles, then the smaller response of histamine may be explained by these factors . And (3) histamine, which has a high rate of turnover in brain (Dismukes and Snyder, 1974) , may be more rapidly catabolized than impromidine.
It is interesting that at the doses of impromidine and histamine producing maximal effects on pial arteriolar diameter, there is also near-maximal acti vation of adenylate cyclase in preparations of hip pocampal homogenates or slices and in cortical mi crovessel fractions (Hegstrand et aI. , 1976; Kar nushina et aI. , 1980; Tuong et aI. , 1980; McNeill, 1980) . The potential importance of histamine sensitive adenylate cyclase to histaminergic mecha nisms in brain, and possibly cerebral vascular re sponses, has been reviewed recently (Green et aI. , 1978; McNeill, 1980; Schwartz et aI. , 1980) .
The microapplication technique has been used previously to characterize pial arteriolar responses to a variety of putative neurotransmitter substances in the central nervous system. At concentrations between 10-9 and 10-4 M, increases in pial arteriolar caliber of 5-40% are produced by a variety of agents, viz. , cholinergic agonists (Wahl and Kus chinsky, 1977) , the ,a-adrenergic agonist iso proterenol (Wahl and Kuschinsky, 1977) , 5hydroxytryptamine (Harper and MacKenzie, 1977) , histamine (Wahl and Kuschinsky, 1979a) , and va soactive intestinal peptide (McCulloch and Ed vinsson, 1980) . The 43% dilatation produced by im promidine at 10-6 M is a more pronounced effect on brain arteriolar caliber than that reported for other neurotransmitters, or their pharmacological agonists.
Responses of Veins
Pial veins were not responsive to stimulation of histamine receptors. Over the two concentrations studied, each of the histamine agents produced very weak dilatations or no response; this absence of vascular responsiveness contrasts with the sen sitivity of pial arterioles (Fig. 2) .
Previous studies using topical administration also indicated that pial veins had relatively small dilata tory responses to histamine (Martins et aI. , 1980) . There are reasons, however, for caution in inter preting the findings of these studies: (1) The ex posed brain was covered only by a thin layer of CSF (1 mm); this can lead to significant loss of carbon dioxide from the cortex and an increase in pH (Navari et aI. , 1978) . (2) The high arterial pressures in their animals may have influ-enced the diameters and reactivity of the pial ves sels. And (3) the concentration of histamine used (cumulative doses up to 10-2 M) was very high and may have had nonspecific effects.
In our studies, the layer of oil over the brain sur face was 15 mm deep, and under these conditions, the pH of subarachnoid fluid is stable (Kuschinsky and Wahl, 1979) ; the arterial blood pressures in our cats were normal (90-120 mm Hg); and the range of histamine concentrations that we studied was from 10-10 to 10-4 M, values similar to those used in other studies (Hegstrand et aI. , 1976; Wahl and Kus chinsky, 1979a; Karnushina et aI. , 1980; Tuong et aI. , 1980) .
In the only other experiments examining re sponses of pial veins to perivascular drug injection, vasoactive intestinal peptide produced venous di latations that were weak relative to arteriolar re sponses (McCulloch and Edvinsson, 1980) .
The lack of cerebral venous response to his tamine receptor stimulation differs from the re sponses of veins in other organs. Intra-arterial infu sion of histamine causes constriction of veins in the human forearm (Sharpey-Schafer and Ginsberg, 1962) . In dog and cat limb preparations, however, histamine may decrease, increase, or not affect venous resistance (Donegan, 1921; Haddy, 1960; Diana and Kaiser, 1970) . H I receptors appear to exclusively mediate constrictor responses to his tamine in the dog saphenous vein (Powell and Brody, 19760) .
Differences in Venous and Arteriolar Responses
Our results indicate that pial venous responses to histamine receptor agonists are negligible when compared to responses seen in pial arterioles. There is previous evidence to suggest that arteries and veins in the same circulatory bed do not have the same response to vasoactive substances. In per fused organs of dogs, for example, venous re sponses are much smaller than arterial responses to isoproterenol (forelimb, Abboud et aI. , 1965) , his tamine (forelimb, Haddy, 1960; hindlimb, Diana and Kaiser, 1970) , dopamine (mesentery, Mark et aI., 1970) , and vasoconstrictor agents (gracilis muscle and hindpaw, Abdel-Sayed et aI. , 19700) .
A variety of factors may explain the disparities in responses between venous and arterial segments.
1.
A structural element. Veins clearly have less smooth muscle than arterioles and therefore like-ly have less capacity for response to most vaso active stimuli. In dog hindlimbs, cutaneous veins are more muscular than deep muscle veins and are more sensitive to infused constrictor agents (Abdel-Sayed et aI., 1970a) .
2. Vessel tone. Due to their lower luminal pres sure, veins have less wall tension, which may con tribute to their low reactivity.
3. The organization and density of receptors may not be the same in veins and arterioles. A spatial differentiation of receptors has been suggested pre viously to explain differences in thermal sensitivity between superficial and deep veins (Abdel-Sayed et aI., 1970h) . In the brain circulation, histamine re ceptors may be poorly distributed, or absent, in veins and more heavily concentrated in precapillary vessels. This arrangement has been described pre viously for adrenergic innervation of vessels in skeletal muscle (Fuxe and Sedvall, 1965) and is thought to be a reason why there are differences between arterial and venous responses to some stimuli in peripheral organs (Abboud et aI., 1976) .
In conclusion, histaminergic stimuli applied to the outside of pial veins produce no significant effect on the caliber of these vessels. Pial arterioles are very sensitive to stimulation of H2 receptors and show only modest dilatatory responses to high concen trations of a drug that stimulates HI receptors. These results suggest two novel concepts concern ing the distribution of histamine receptors in the cerebral circulation: (1) histamine receptors are poorly distributed or absent on the outer surfaces of veins, and (2) H2 receptors are predominant in outer layers of smooth muscle in arterioles.
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